News › Clinical Practice, Industry News, Patient Care

Laseroptek Co. Ltd. Announces U.S. Launch of Pallas Solid-state UVB Medical Dermatology Laser

August 12, 2020

Laseroptek Co. Ltd., a developer and manufacturer of laser devices for aesthetic and medical dermatology, has announced the launch of its Pallas solid-state 311-nm UVB laser in the United States. The Pallas laser is FDA-cleared for the treatment of vitiligo, psoriasis, atopic dermatitis and leukoderma.
Pallas is the fifth Laseroptek laser device to receive FDA clearance in the U.S. for dermatological treatments and brings to the U.S. market the world’s first solid-state UVB laser delivering efficacious and safe treatment for a variety of skin conditions that collectively affect close to a billion people worldwide.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • BTL Establishes New Laser Division and Introduces Exolase One
    • ASPS 2025 Statistics Report Highlights Continued Demand for Aesthetic Treatments, Volume Restoration and Healthy Aging
    • SkinMedica Launches Barrier Calming Cream
    • CEDR HR Solutions Supports AmSpa Members as Platinum Vendor Affiliate
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
Advertisement